Skip to content

Insider · CIK 0001875501

Sean Mackay

officer

Files at LAB (STANDARD BIOTOOLS INC.). First filing May 23, 2025, latest May 28, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $38k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LAB: STANDARD BIOTOOLS INC.

LABOct 9, 2026 · close 0.69

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
LABsell 3
STANDARD BIOTOOLS INC.
$12k
13,217 shares
-2%0% from low-59% from high
35Weak
LABsell 3
STANDARD BIOTOOLS INC.
$26k
25,374 shares
-3%+3% from low-54% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Aug 20, 2025LAB
STANDARD BIOTOOLS INC.
FTax withholding
Common Stock
-19,661$1.27$25k799,496Aug 22, 2025
May 28, 2025LAB
STANDARD BIOTOOLS INC.
FTax withholding
Common Stock
-23,919$1.09$26k819,157May 30, 2025
May 23, 2025LAB
STANDARD BIOTOOLS INC.
SOpen-market sale
Common Stock
-13,217$0.94$12k843,076May 28, 2025
May 21, 2025LAB
STANDARD BIOTOOLS INC.
SOpen-market sale
Common Stock
-12,838$1.03$13k868,829May 23, 2025
May 22, 2025LAB
STANDARD BIOTOOLS INC.
SOpen-market sale
Common Stock
-12,536$1.00$13k856,293May 23, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Sean Mackay: insider trades and track record | InsiderTell